Related Experiment Video
Updated: Nov 2, 2025
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.6K
Ventricular Assist Device Therapy in the Fontan Circulation.
Chet R Villa1, Angela Lorts1, David L S Morales1
1The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Summary
Ventricular assist devices (VADs) offer effective treatment for Fontan patients experiencing circulatory failure. This review details current strategies for patient selection, implantation, and management of these complex cases.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Mechanical Circulatory Support
Background:
- Fontan-associated circulatory failure and systolic dysfunction are increasing.
- Ventricular assist devices (VADs) have emerged as a viable treatment option.
- Proper patient selection is crucial for VAD therapy success.
Purpose of the Study:
- To outline the current approach to managing Fontan patients with VADs.
- To discuss patient selection criteria for VAD implantation.
- To review VAD implantation and post-implantation management strategies.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of patient selection criteria for VADs in Fontan circulation.
- Discussion of surgical implantation techniques and perioperative care.
- Outline of long-term management protocols for VAD support.
Main Results:
- VAD therapy has shown efficacy in selected Fontan patients with end-stage heart failure.
- Careful patient selection improves outcomes and reduces complications.
- Multidisciplinary management is essential for optimizing VAD support.
Conclusions:
- VADs represent an important therapeutic option for Fontan survivors with advanced heart failure.
- A standardized approach to selection, implantation, and management is necessary.
- Ongoing research is needed to further refine VAD therapy in this population.
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
69
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
69
01:29Cardiomyopathy V: Interprofessional Care
93
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
01:30Cardiomyopathy II: Dilated Cardiomyopathy
111
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
01:25Hemodialysis I: Introduction
543
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
543
01:30Heart Failure V: Medical Management
60
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
60